Solstice Neurosciences
Latest round
- Series B
Last raised
- Nov 2006
Total raised
- $45M
Investors
- 5
About Solstice Neurosciences
Solstice Neurosciences specializes in the research and development of drugs targeted at neurological conditions.70 mn.Solstice Neurosciences produces a range of innovative therapeutics aimed at treating patients with neurological disorders. Their core offerings include prescription medications that target chronic health issues, improving patient outcomes across diverse markets, including the US, Europe, and parts of Asia.Revenue is generated primarily through the distribution of pharmaceutical products via partnerships with wholesalers and specialty pharmacies.Solstice Neurosciences aims to expand its product line with new therapeutic offerings, although specific upcoming products have not been disclosed. The company is exploring opportunities for market entry into additional geographic regions beyond its current operations, leveraging insights gained from its acquisition by US WorldMeds.70 mn Trade Sale in August 2010 will be allocated to support these initiatives and strengthen its position in the healthcare market.
Who invested in Solstice Neurosciences
5 investors across 1 round
See all investors in Solstice Neurosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 8, 2006
Amount
$45M
Investors
Questions about Solstice Neurosciences
Who invested in Solstice Neurosciences?
Solstice Neurosciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Solstice Neurosciences raised?
Solstice Neurosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Solstice Neurosciences last raise money?
Solstice Neurosciences's most recent round on record is a Series B, in Nov 2006.
What does Solstice Neurosciences do?
Solstice Neurosciences specializes in the research and development of drugs targeted at neurological conditions.
Where is Solstice Neurosciences headquartered?
Solstice Neurosciences is headquartered in South San Francisco, US.
Which VCs invest in companies like Solstice Neurosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Solstice Neurosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Solstice Neurosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.